Larry Page the chief executive officer of Google, recently announced that Google
will fund and independent company called Calico. Calico will be managed by Arthur
Levinson, a former executive with bio – technology leader Genentech.
While the specific plans of Calico have not been revealed by Google, the company
has stated that Calico will focus on researching and developing technology to combat
the aging process and eradicate diseases that reduce the average life span of humans.
Calico’s time line will be in a ten to twenty year window, with no short term pressure
to produce sales and profits for Google. Calico will take a position of the aging
process as a disease and look to develop bio – technologies that are anti – aging
and to solve the mystery of why certain diseases such as cancer exist rather than
just looking to cure cancer.
Anti Aging and Google
Google has a fifty billion dollar reserve of cash, but has not revealed how much
will be invested in Calico. Google’s deep pockets combined with the intellectual
capital of Silicon Valley and the company’s expertise in mining, managing, processing,
and analyzing data lend excitement to the anticipation of what Calico can accomplish
twenty years from now.
Today medical doctors manage large amounts of data such as blood tests, MRI, X-
Ray, Ultra Sound, and biopsy results. Calico will look to develop new technologies
from the data currently available.
At the Anti Aging Institute of The Americas we look at anti – aging medicine as
helping patients manage the non – DNA factors of their personal health. Focusing
on their life style and environment combined with bio – identical hormone replacement.
Our goal is to help patients maximize the quality of their lives looking and feeling
younger than their peers.
Under the guidelines of The American Academy of Anti Aging Medicine, The Anti Aging
Institute of The Americas will look forward to seeing what new technologies Calico
develops that are appropriate for our patients.